Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
General Mills, Inc. stock logo
GIS
General Mills
$34.57
+0.4%
$38.37
$33.58
$55.35
$18.37B-0.028.01 million shs8.72 million shs
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$989.02
+2.2%
$946.66
$623.78
$1,133.95
$911.54B0.483.22 million shs2.95 million shs
7 Stocks to Buy Before SpaceX Goes Public Cover

SpaceX has quietly filed to go public later this year. Ahead of what's expected to be the largest IPO of all time, there are seven space stocks that you can buy today that are positioned to benefit from accelerating space commercialization in 2026.

These seven companies are shaping the next phase of the space economy—from launch leaders and satellite networks to data, defense, and in-space infrastructure.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
General Mills, Inc. stock logo
GIS
General Mills
0.00%-0.03%-7.15%-25.25%-37.32%
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
0.00%+11.12%+3.13%-3.79%+16.98%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
General Mills, Inc. stock logo
GIS
General Mills
$34.57
+0.4%
$38.37
$33.58
$55.35
$18.37B-0.028.01 million shs8.72 million shs
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$989.02
+2.2%
$946.66
$623.78
$1,133.95
$911.54B0.483.22 million shs2.95 million shs
7 Stocks to Buy Before SpaceX Goes Public Cover

SpaceX has quietly filed to go public later this year. Ahead of what's expected to be the largest IPO of all time, there are seven space stocks that you can buy today that are positioned to benefit from accelerating space commercialization in 2026.

These seven companies are shaping the next phase of the space economy—from launch leaders and satellite networks to data, defense, and in-space infrastructure.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
General Mills, Inc. stock logo
GIS
General Mills
0.00%-0.03%-7.15%-25.25%-37.32%
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
0.00%+11.12%+3.13%-3.79%+16.98%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
General Mills, Inc. stock logo
GIS
General Mills
1.90
Reduce$43.2225.03% Upside
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
2.87
Moderate Buy$1,217.5923.11% Upside

Current Analyst Ratings Breakdown

Latest GIS and LLY Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/5/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
Reiterated RatingBuy$1,183.00
5/4/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
Reiterated RatingOutperform$1,325.00
5/4/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
Boost Price TargetOverweight$1,350.00 ➝ $1,400.00
5/1/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
Reiterated RatingOverweight$1,344.00
5/1/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
Lower Price TargetBuy$1,294.00 ➝ $1,133.00
5/1/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
Boost Price TargetOverweight$1,205.00 ➝ $1,230.00
5/1/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
Boost Price TargetBuy$1,260.00 ➝ $1,283.00
4/27/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
Lower Price TargetOutperform$1,296.00 ➝ $1,058.00
4/21/2026
General Mills, Inc. stock logo
GIS
General Mills
Lower Price TargetBuy$44.00 ➝ $40.00
4/21/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
Boost Price TargetBuy$1,163.00 ➝ $1,183.00
4/13/2026
General Mills, Inc. stock logo
GIS
General Mills
Initiated CoverageNeutral
(Data available from 5/5/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
General Mills, Inc. stock logo
GIS
General Mills
$19.49B0.95$5.34 per share6.47$16.98 per share2.04
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$65.18B14.29$25.68 per share38.51$33.13 per share29.85
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
General Mills, Inc. stock logo
GIS
General Mills
$2.30B$4.098.4510.51N/A12.05%19.19%5.48%6/24/2026 (Estimated)
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$20.64B$28.1535.1323.011.0734.98%105.77%23.76%N/A

Latest GIS and LLY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/30/2026Q1 2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$6.97$8.55+$1.58$8.26$17.82 billion$19.80 billion
3/18/2026Q3 2026 Prepared Remarks
General Mills, Inc. stock logo
GIS
General Mills
$0.73$0.64-$0.09$0.56$4.53 billion$4.44 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
General Mills, Inc. stock logo
GIS
General Mills
$2.447.06%+4.13%59.66%5 Years
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$6.920.70%+15.18%24.58%11 Years

Latest GIS and LLY Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/4/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
quarterly$1.730.72%5/15/20265/15/20266/10/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
General Mills, Inc. stock logo
GIS
General Mills
1.17
0.56
0.36
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
1.26
1.50
1.10

Institutional Ownership

CompanyInstitutional Ownership
General Mills, Inc. stock logo
GIS
General Mills
75.71%
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
82.53%

Insider Ownership

CompanyInsider Ownership
General Mills, Inc. stock logo
GIS
General Mills
0.30%
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
0.14%
CompanyEmployeesShares OutstandingFree FloatOptionable
General Mills, Inc. stock logo
GIS
General Mills
33,000533.68 million532.08 millionOptionable
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
50,000941.74 million943.50 millionOptionable

Recent News About These Companies

Alkermes plc Q1 2026 Earnings Call Summary
Top Pharmaceutical Stocks To Research - May 5th
Novo Nordisk’s Weight-Loss Pill Momentum Faces Pricing Pressure
Eli Lilly: No Big Gap To Competition

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
General Mills stock logo

General Mills NYSE:GIS

$34.57 +0.14 (+0.41%)
Closing price 03:59 PM Eastern
Extended Trading
$34.63 +0.06 (+0.17%)
As of 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

General Mills, Inc. manufactures and markets branded consumer foods worldwide. The company operates through four segments: North America Retail; International; Pet; and North America Foodservice. It offers grain, ready-to-eat cereals, refrigerated yogurt, soup, meal kits, refrigerated and frozen dough products, dessert and baking mixes, bakery flour, frozen pizza and pizza snacks, snack bars, fruit and savory snacks, ice cream and frozen desserts, unbaked and fully baked frozen dough products, frozen hot snacks, ethnic meals, side dish mixes, frozen breakfast and entrees, nutrition bars, and frozen and shelf-stable vegetables. The company also manufactures and markets pet food products, including dog and cat food; and operates ice cream parlors. It markets its products under the Annie's, Betty Crocker, Bisquick, Blue Buffalo, Bugles, Cascadian Farm, Cheerios, Chex, Cinnamon Toast Crunch, Cocoa Puffs, Cookie Crisp, Dunkaroos, Edgard & Cooper, Fiber One, Fruit by the Foot, Fruit Gushers, Fruit Roll-Ups, Gardetto's, Gold Medal, Golden Grahams, Häagen-Dazs, Kitano, Kix, Lärabar, Latina, Lucky Charms, Muir Glen, Nature Valley, Nudges, Oatmeal Crisp, Old El Paso, Pillsbury, Progresso, Tastefuls, Total, Totino's , Trix, True Chews, True Solutions, Wanchai Ferry, Wheaties, Wilderness, and Yoki brands. The company sells its products to grocery stores, mass merchandisers, membership stores, natural food chains, drug, dollar and discount chains, e-commerce retailers, commercial and noncommercial foodservice distributors and operators, restaurants, convenience stores, and pet specialty stores. General Mills, Inc. was founded in 1866 and is headquartered in Minneapolis, Minnesota.

Eli Lilly and Company stock logo

Eli Lilly and Company NYSE:LLY

$989.02 +21.09 (+2.18%)
Closing price 03:59 PM Eastern
Extended Trading
$984.48 -4.54 (-0.46%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, including Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, Tyvyt, and Verzenio. In addition, the company offers Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis; Omvoh for ulcerative colitis; Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Ebglyss for severe atopic dermatitis; and Emgality for migraine prevention and episodic cluster headache. Further, it provides Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. It has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; F. Hoffmann-La Roche Ltd and Genentech, Inc.; Biologics, Inc., AbCellera Biologics Inc.; and Chugai Pharmaceutical Co., Ltd. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.